These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 10997960)
1. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Lange B Br J Haematol; 2000 Sep; 110(3):512-24. PubMed ID: 10997960 [No Abstract] [Full Text] [Related]
2. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Ravindranath Y; Abella E; Krischer JP; Wiley J; Inoue S; Harris M; Chauvenet A; Alvarado CS; Dubowy R; Ritchey AK Blood; 1992 Nov; 80(9):2210-4. PubMed ID: 1384797 [TBL] [Abstract][Full Text] [Related]
3. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ; Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG). van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546 [TBL] [Abstract][Full Text] [Related]
5. Acute lymphoblastic leukemia in infants: a decade of experience in the Czech Republic. Jabali Y; Starý J; Hak J; Blazek B; Hrstkova H; Mihál V; Mydlil J; Timr P; Gajdos P Med Pediatr Oncol; 2000 Nov; 35(5):493-5. PubMed ID: 11070483 [No Abstract] [Full Text] [Related]
6. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699 [TBL] [Abstract][Full Text] [Related]
7. Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial. Millot F; Suciu S; Philippe N; Benoit Y; Mazingue F; Uyttebroeck A; Lutz P; Mechinaud F; Robert A; Boutard P; Marguerite G; Ferster A; Plouvier E; Rialland X; Behard C; Plantaz D; Dresse MF; Philippet P; Norton L; Thyss A; Dastugue N; Waterkeyn C; Vilmer E; Otten J; J Clin Oncol; 2001 Apr; 19(7):1935-42. PubMed ID: 11283125 [TBL] [Abstract][Full Text] [Related]
8. Improved treatment results in boys with overt testicular relapse during or shortly after initial therapy for acute lymphoblastic leukemia. A Pediatric Oncology group study. Buchanan GR; Boyett JM; Pollock BH; Smith SD; Yanofsky RA; Ghim T; Wharam MD; Crist WM; Vietti TJ; Johnson W Cancer; 1991 Jul; 68(1):48-55. PubMed ID: 2049752 [TBL] [Abstract][Full Text] [Related]
9. Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours. Renard M; Suciu S; Bertrand Y; Uyttebroeck A; Ferster A; van der Werff Ten Bosch J; Mazingue F; Plouvier E; Robert A; Boutard P; Millot F; Munzer M; Mechinaud F; Lescoeur B; Baila L; Vandecruys E; Benoit Y; Philippet P; Pediatr Blood Cancer; 2011 Jul; 57(1):119-25. PubMed ID: 21412967 [TBL] [Abstract][Full Text] [Related]
10. Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia. Eguiguren JM; Pui CH Med Pediatr Oncol; 1992; 20(1):58-60. PubMed ID: 1727213 [TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95. Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312 [No Abstract] [Full Text] [Related]
12. Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Locatelli F; Zecca M; Messina C; Rondelli R; Lanino E; Sacchi N; Uderzo C; Fagioli F; Conter V; Bonetti F; Favre C; Porta F; Giorgiani G; Pession A Leukemia; 2002 Nov; 16(11):2228-37. PubMed ID: 12399966 [TBL] [Abstract][Full Text] [Related]
13. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group. Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M; Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916 [TBL] [Abstract][Full Text] [Related]
14. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study. Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M; Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410 [TBL] [Abstract][Full Text] [Related]
16. Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)? Jakab Z; Balogh E; Karászi E; Kappelmayer J; Kiss C; Oláh E Med Pediatr Oncol; 2002 Jul; 39(1):63-5. PubMed ID: 12116086 [No Abstract] [Full Text] [Related]
17. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group]. Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V; Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem]. Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412 [No Abstract] [Full Text] [Related]
19. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Marshall GM; Dalla Pozza L; Sutton R; Ng A; de Groot-Kruseman HA; van der Velden VH; Venn NC; van den Berg H; de Bont ES; Maarten Egeler R; Hoogerbrugge PM; Kaspers GJ; Bierings MB; van der Schoot E; van Dongen J; Law T; Cross S; Mueller H; de Haas V; Haber M; Révész T; Alvaro F; Suppiah R; Norris MD; Pieters R Leukemia; 2013 Jul; 27(7):1497-503. PubMed ID: 23407458 [TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]